94 related articles for article (PubMed ID: 21259400)
21. Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig.
Kimura H; Kawatani M; Ito E; Ishikawa K
Laryngoscope; 2003 Jun; 113(6):1000-6. PubMed ID: 12782812
[TBL] [Abstract][Full Text] [Related]
22. Pituitary adenylate cyclase-activating polypeptide directly stimulates LH and FSH secretion by human pituitary gonadotrophinomas.
Petersen B; Buchfelder M; Fahlbusch R; Adams EF
Exp Clin Endocrinol Diabetes; 1996; 104(3):250-5. PubMed ID: 8817243
[TBL] [Abstract][Full Text] [Related]
23. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
[TBL] [Abstract][Full Text] [Related]
24. Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta.
Koh PO; Won CK; Noh HS; Cho GJ; Choi WS
J Vet Sci; 2005 Mar; 6(1):1-5. PubMed ID: 15785117
[TBL] [Abstract][Full Text] [Related]
25. Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactivity in the brain of a teleost, Uranoscopus japonicus: immunohistochemical relationship between PACAP and adenohypophysial hormones.
Matsuda K; Nagano Y; Uchiyama M; Onoue S; Takahashi A; Kawauchi H; Shioda S
Regul Pept; 2005 Mar; 126(1-2):129-36. PubMed ID: 15620426
[TBL] [Abstract][Full Text] [Related]
26. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Nilsson SF; De Neef P; Robberecht P; Christophe J
Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
[TBL] [Abstract][Full Text] [Related]
27. [Structure, localization and physiologic role of pituitary adenylate cyclase activating polypeptide (PACAP)].
Vincze E; Köves K
Orv Hetil; 2001 Mar; 142(10):491-6. PubMed ID: 11288374
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenylate cyclase-activating polypeptide-like compounds could modulate the activity of coelomocytes in the earthworm.
Somogyi I; Boros A; Engelmann P; Varhalmi E; Nemeth J; Lubics A; Tamas A; Kiss P; Reglodi D; Pollak E; Molnar L
Ann N Y Acad Sci; 2009 Apr; 1163():521-3. PubMed ID: 19456404
[TBL] [Abstract][Full Text] [Related]
29. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
Margiotta JF; Pardi D
Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776
[TBL] [Abstract][Full Text] [Related]
30. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
[TBL] [Abstract][Full Text] [Related]
31. Examination of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) as a Potential Biomarker in Heart Failure Patients.
Sarszegi Z; Szabo D; Gaszner B; Konyi A; Reglodi D; Nemeth J; Lelesz B; Polgar B; Jungling A; Tamas A
J Mol Neurosci; 2019 Jul; 68(3):368-376. PubMed ID: 29353438
[TBL] [Abstract][Full Text] [Related]
32. Environmental enrichment increases PACAP levels in the CNS of adult rats.
Horvath G; Kiss P; Nemeth J; Lelesz B; Tamas A; Reglodi D
Neuro Endocrinol Lett; 2015; 36(2):143-7. PubMed ID: 26071583
[TBL] [Abstract][Full Text] [Related]
33. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.
Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J
Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374
[TBL] [Abstract][Full Text] [Related]
34. Examination of PACAP38-like immunoreactivity in different milk and infant formula samples.
Csanaky K; Reglődi D; Bánki E; Tarcai I; Márk L; Helyes Z; Ertl T; Gyarmati J; Horváth K; Sántik L; Tamás A
Acta Physiol Hung; 2013 Mar; 100(1):28-36. PubMed ID: 23471040
[TBL] [Abstract][Full Text] [Related]
35. Phospholipid compositions of sera and synovial fluids from dog, human and horse: a comparison by 31P-NMR and MALDI-TOF MS.
Fuchs B; Bondzio A; Wagner U; Schiller J
J Anim Physiol Anim Nutr (Berl); 2009 Aug; 93(4):410-22. PubMed ID: 18484967
[TBL] [Abstract][Full Text] [Related]
36. Examination of PACAP-Like Immunoreactivity in Urogenital Tumor Samples.
Tamas A; Javorhazy A; Reglodi D; Sarlos DP; Banyai D; Semjen D; Nemeth J; Lelesz B; Fulop DB; Szanto Z
J Mol Neurosci; 2016 Jun; 59(2):177-83. PubMed ID: 26454744
[TBL] [Abstract][Full Text] [Related]
37. Female reproductive functions of the neuropeptide PACAP.
Koppan M; Nagy Z; Bosnyak I; Reglodi D
Front Endocrinol (Lausanne); 2022; 13():982551. PubMed ID: 36204113
[TBL] [Abstract][Full Text] [Related]
38. Transcriptomics and proteomics analyses of the PACAP38 influenced ischemic brain in permanent middle cerebral artery occlusion model mice.
Hori M; Nakamachi T; Rakwal R; Shibato J; Ogawa T; Aiuchi T; Tsuruyama T; Tamaki K; Shioda S
J Neuroinflammation; 2012 Nov; 9():256. PubMed ID: 23176072
[TBL] [Abstract][Full Text] [Related]
39. Identification and evaluation of potential forensic marker proteins in vaginal fluid by liquid chromatography/mass spectrometry.
Igoh A; Doi Y; Sakurada K
Anal Bioanal Chem; 2015 Sep; 407(23):7135-44. PubMed ID: 26164306
[TBL] [Abstract][Full Text] [Related]
40. Comparative protein composition of the brains of PACAP-deficient mice using mass spectrometry-based proteomic analysis.
Maasz G; Pirger Z; Reglodi D; Petrovics D; Schmidt J; Kiss P; Rivnyak A; Hashimoto H; Avar P; Jambor E; Tamas A; Gaszner B; Mark L
J Mol Neurosci; 2014 Nov; 54(3):310-9. PubMed ID: 24643519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
